DEFINING THE IDEAL TUMOR MARKER FOR PROSTATE CANCER
- 1 May 1997
- journal article
- Published by Elsevier in Urologic Clinics of North America
- Vol. 24 (2) , 247-252
- https://doi.org/10.1016/s0094-0143(05)70369-4
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Current prognostic factors for prostate carcinomaCancer, 1996
- Distant metastasis after radical prostatectomy in patients without an elevated serum prostate specific antigen levelCancer, 1995
- Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screeningPublished by American Medical Association (AMA) ,1995
- Long-term survival among men with conservatively treated localized prostate cancerPublished by American Medical Association (AMA) ,1995
- Dangers of Using "Optimal" Cutpoints in the Evaluation of Prognostic FactorsJNCI Journal of the National Cancer Institute, 1994
- Criteria for prognostic factors and for an enhanced prognostic systemCancer, 1993
- Prostate Specific Antigen Density: A Means of Distinguishing Benign Prostatic Hypertrophy and Prostate CancerJournal of Urology, 1992
- The Effect of Radiation Therapy after Radical Prostatectomy in Patients with Elevated Prostate Specific Antigen LevelsJournal of Urology, 1990
- Prostate Carcinoma: An Autopsy Evaluation of the Influence of Age, Tumor Grade, and Therapy on Tumor BiologySouthern Medical Journal, 1990
- AN “ ACID ” PHOSPHATASE OCCURRING IN THE SERUM OF PATIENTS WITH METASTASIZING CARCINOMA OF THE PROSTATE GLANDJournal of Clinical Investigation, 1938